Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients (EpiMicro)

The main goal of this project is to study the mechanisms of epileptic activities using intracranial macro and micro electrodes in epileptic patients undergoing pre-surgical investigation.

The recordings will also be used to study physiological mechanisms like sleep and different cognitive functions.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Paris, France, 7501F3
        • Recruiting
        • Hôpital de la Salpêtrière
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with focal drug-resistant epilepsy
  • Patients who undergo a presurgical evaluation with intracranial electrodes in the videoEEG unit of the Neurology department at the Pitié-Salpêtrière hospital.
  • Patients who have been informed and provided written informed consent to take part in the study

Exclusion Criteria:

  • Contraindication for an intracranial investigation (with macro-electrodes) : intercurrent infectious syndrome, decompensated associated pathology (cardiac, pulmonary, renal, hepatic), patient with increased risk of infection (ex: under immunosuppressive therapy)
  • Pregnant or parturient woman
  • Breastfeeding woman
  • Minor person or legally protected adult (tutelage, legal guardianship, maintenance of justice)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Macro-microelectrode implantation
Implantation of macro-micro electrodes of the Adtech Benkhe-Fried type in epileptic patients who are undergoing evaluation with intracranial EEG electrodes
Additionnally to clinical macroelectrodes, Benkhe-Fried depth macro-microelectrodes will be implanted and recorded during the pre-surgical investigation of epileptic patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identification of single unit changes at seizure emergence
Time Frame: Whole duration of the clinical inverstigation, until 4 weeks

In order to identify biomarkers of epileptic seizures we will study single neuron activities (firing rate) using spike sorting at different time periods (before, during and after seizures and during interictal periods)

We expect to observe significant changes in firing rate across the different time periods.

Whole duration of the clinical inverstigation, until 4 weeks
Identification of local field potential (LFP) changes at seizure emergence
Time Frame: Whole duration of the clinical inverstigation, until 4 weeks

In order to identify biomarkers of epileptic seizures we will study LFP power using time frequency analysis at different time periods (before, during and after seizures and during interictal periods)

We expect to observe significant changes in LFP power across the different time periods.

Whole duration of the clinical inverstigation, until 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of single unit activity before seizure according to brain localization
Time Frame: Whole duration ofthe clinical inverstigation, until 4 weeks
We will compare firing rate before seizure according to brain regions (anatomy and involvement in the seizure onset zone)
Whole duration ofthe clinical inverstigation, until 4 weeks
Identification of single unit changes during physiological brain activity
Time Frame: Whole duration ofthe clinical inverstigation, until 4 weeks

We will compare firing rates during resting states and stimulus induced states.

We expect to observe significant changes in firing rate between states.

Whole duration ofthe clinical inverstigation, until 4 weeks
Identification of LFP power changes during physiological brain activity
Time Frame: Whole duration ofthe clinical inverstigation, until 4 weeks

We will compare LFP power during resting states and stimulus induced states.

We expect to observe significant changes in LFP power between states.

Whole duration ofthe clinical inverstigation, until 4 weeks
Multilevel study of brain activity
Time Frame: Whole duration ofthe clinical inverstigation, until 4 weeks
We will look for correlation between firing rates and LFP power changes.
Whole duration ofthe clinical inverstigation, until 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2021

Primary Completion (Estimated)

February 27, 2029

Study Completion (Estimated)

February 27, 2031

Study Registration Dates

First Submitted

November 5, 2020

First Submitted That Met QC Criteria

November 25, 2020

First Posted (Actual)

December 4, 2020

Study Record Updates

Last Update Posted (Estimated)

September 8, 2025

Last Update Submitted That Met QC Criteria

September 2, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Function

Clinical Trials on Intracranial macro-microelectrode recording

Subscribe